Naomi Ko | Profiles RNS

Naomi Y Ko, MD, MPH

Associate Professor

Boston University Chobanian & Avedisian School of Medicine

Medicine

Hematology & Medical Oncology

MD, Johns Hopkins University School of Medicine
MPH, Johns Hopkins University School of Public Health
AM, Harvard University
BA, Barnard College

Pronouns: she/her/hers

Websites

	Boston Medical Center Provider Profile
	Radio Boston Financial Toxicity of Cancer
	A Look at the Patient Navigator Program in Breast Cancer
	Radio MD Breast Cancer 101
	WBZ radio link 2020
	ResearchGate
	WGBH Basic Black

ORCID : 0000-0001-9689-9601

Breast Cancer
Cancer Disparities
Health Equity

Dr. Ko is an Associate Professor of Medicine at Chobanian and Avedisian School of Medicine (BUSM) and a medical oncologist at Boston Medical Center (BMC) who has a lifelong passion for social justice. After college, Dr. Ko participated in Teach For America followed by volunteer service at the Berkeley Free Clinic in the Bay Area. She went on to Johns Hopkins School of Medicine and School of Public Health to complete her MD MPH with a focus on health outcomes research for vulnerable populations. After internal medicine residency at Brigham and Women's Hospital she arrived for fellowship in hematology/oncology at BUSM/BMC, which allowed Dr. Ko to conduct research in the context of caring for an underserved population within a large safety net institution. She has sought out meaningful projects that are a culmination of her passion for oncology, service to the underserved, and academic research. Her research has a translational focus that has been directed to understanding the disconnect between scientific discoveries in cancer treatment and delivery of evidence-based treatment to vulnerable, racial/ethnic minority women with breast cancer. She is actively investigating how tumor biology, poverty, communication and treatment influence breast cancer outcomes in diverse breast cancer populations.

Diversity, Equity, Inclusion and Accessibility

I am the child of Chinese immigrants. Growing up with parents who dedicated their lives to the enduring hope of the American dream for their children and grandchildren has shaped my values and guided my life choices. I seek to right the imbalance in our society with dedicated service for those who are vulnerable to structural racism, sexism and other inequalities inherent in our society. From my decision to be an American Studies major in college, to my participation in Teach for America and volunteer work at the Berkeley Free Clinic, I have consistently sought opportunities to understand, respect and serve communities in need.

It is a privilege and honor to treat patients and families who find Boston Medical Center (formerly Boston City Hospital) to be their medical home. As the largest safety net hospital in New England, I am grateful to practice alongside providers who strive for exceptional care without exception. My research is singularly focused on breast cancer disparities (see other tabs). In 2019 I participated in the BRIM (Bias Reduction in Medicine) training. Currently, I am on both the Section Anti-Racism Committee and Women in Oncology group.

Member
Boston University
BU-BMC Cancer Center

Member
Boston University
Center for Excellence in Women’s Health

Member
Boston University
Evans Center for Interdisciplinary Biomedical Research

BMC Research
NIH RePORTER Research

Subclonal heterogeneity and outcome disparities in Triple-Negative Breast Cancer among African Americans
04/01/2022 - 03/31/2026 (Multi-PI)
PI: Naomi Y Ko, MD, MPH
The General Hospital Corporation / MGH NIH NCI
1R01CA248923-01A1

Multidimensional Markers of Response and Resistance in advanced breast cancer: CDK4/6 Inhibitors (HR+/HER2-)
11/08/2022 - 11/07/2025 (PI)
Bristol-Myers Squibb Company

Multiscale analysis of metabolic inflammation as a driver of breast cancer
09/09/2020 - 08/31/2025 (Subcontract PI)
PI: Naomi Y Ko, MD, MPH
Trustees of Boston University, BUMC NIH NCI

Landscape and characterization of promoter mutations driving triple-negative breast cancer
07/13/2023 - 06/30/2025 (Subcontract PI)
PI: Naomi Y Ko, MD, MPH
Massachusetts General Hospital NIH
1R21CA284602-01

Phase 1b/2 Study to Evaluate Safety and Anti-Tumor Activity of Antibody-Drug Conjugate Sacituzumab Govitecan in Combination with the Poly (Adenosine Diphosphate [ADP]-Ribose) Polymerase (PARP) Inhibitor Talazoparib in Patients with Metastatic Triple-Nega
06/07/2022 - 12/06/2024 (PI)
Dana Farber Cancer Institute

Mechanisms of BET bromodomain metabolic reprogramming in triple negative breast cancer
08/01/2019 - 07/31/2024 (Subcontract PI)
PI: Naomi Y Ko, MD, MPH
Trustees of Boston University, BUMC NIH NCI
1R01CA222170-01A1

A wearable probe for deep tissue imaging of hemodynamics in breast tumors
01/01/2022 - 06/30/2024 (Subcontract PI)
PI: Naomi Y Ko, MD, MPH
Trustees of Boston University, BUMC Amer Cancer Society

Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer – Core A
07/05/2019 - 05/31/2024 (Subcontract PI)
PI: Naomi Y Ko, MD, MPH
Dana Farber Cancer Institute NIH NCI
2P50CA168504-06A1

Increasing Receipt of Guideline Concordant Survivorship Care Among Black Breast Cancer Survivors…
01/01/2020 - 12/31/2023 (Subcontract PI)
PI: Naomi Y Ko, MD, MPH
Massachusetts General Hospital Pfizer, Inc

DFCI 17-101: Palbociclib After CDK and Endocrine Therapy (PACE): A Randomized Phase II Study…
01/02/2020 - 01/01/2023 (PI)
Dana Farber Cancer Institute

Showing 10 of 14 results. Show All Results

Title

Yr	Title	Project-Sub Proj
2025	Subclonal heterogeneity and outcome disparities in Triple-Negative Breast Cancer among African Americans	5R01CA248923-04
2024	Subclonal heterogeneity and outcome disparities in Triple-Negative Breast Cancer among African Americans	5R01CA248923-03
2023	Subclonal heterogeneity and outcome disparities in Triple-Negative Breast Cancer among African Americans	5R01CA248923-02
2022	Subclonal heterogeneity and outcome disparities in Triple-Negative Breast Cancer among African Americans	1R01CA248923-01A1

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis Copy PMIDs To Clipboard

Bar Y, Fell G, Dedeoglu A, Moffett N, Vidula N, Spring L, Wander SA, Bardia A, Ko N, Moy B, Ellisen LW, Isakoff SJ. Dynamic HER2-low status among patients with triple negative breast cancer (TNBC) and the impact of repeat biopsies. NPJ Breast Cancer. 2025 Mar 11; 11(1):27. PMID: 40069204; PMCID: PMC11897376; DOI: 10.1038/s41523-025-00741-y;

Qiu Y, Chen A, Yu R, Llevenes P, Seen M, Ko NY, Monti S, Denis GV. Insulin Resistance Increases TNBC Aggressiveness and Brain Metastasis via Adipocyte-derived Exosomes. Mol Cancer Res. 2025 Mar 06.View Related Profiles.

Denis, Gerald
Ko, Naomi
Monti, Stefano

PMID: 40047645; DOI: 10.1158/1541-7786.MCR-24-0494;

Oshry LJ, Lederman RI, Gagnon H, Fikre T, Gundersen DA, Revette AC, Odai-Afotey A, Kantor O, Hershman DL, Crew KD, Keating NL, Freedman RA, Ko NY. Racial discrimination among women seeking breast cancer care. NPJ Breast Cancer. 2025 Jan 16; 11(1):4.View Related Profiles.

Oshry, Lauren
Ko, Naomi

PMID: 39819887; PMCID: PMC11739410; DOI: 10.1038/s41523-025-00717-y;

Ko N, Oshry L, Lederman R, Gagnon H, Fikre T, Gundersen D, Revette A, Odai-Afotey A, Kantor O, Hershman D, Crew K, Keating N, Freedman R. See Me, Hear Me: Racial Discrimination Among Women Seeking Breast Cancer Care. Res Sq. 2024 Sep 20.View Related Profiles.

Oshry, Lauren
Ko, Naomi

PMID: 39372929; PMCID: PMC11451816; DOI: 10.21203/rs.3.rs-4837604/v1;

Ennis CS, Seen M, Chen A, Kang H, Ilinski A, Mahdaviani K, Ko N, Monti S, Denis GV. Plasma exosomes from individuals with type 2 diabetes drive breast cancer aggression in patient-derived organoids. bioRxiv. 2024 Sep 19.View Related Profiles.

Denis, Gerald
Mahdaviani, Kiana
Ko, Naomi
Monti, Stefano

PMID: 39345362; PMCID: PMC11429695; DOI: 10.1101/2024.09.13.612950;

Beaulieu-Jones BR, Ha EJ, Fefferman A, Wang J, Chung SH, Tseng JF, Merrill A, Sachs TE, Ko NY, Cassidy MR. ASO Visual Abstract: Association of Race, Ethnicity, Language and Insurance and Time to Treatment Initiation Among Women with Breast Cancer at an Urban, Academic, Safety-Net Hospital. Ann Surg Oncol. 2024 Jul 03.View Related Profiles.

Merrill, Andrea
Fefferman, Ann
Beaulieu-Jones, Brendin
Ha, Emily
Tseng, Jennifer
Cassidy, Michael
Ko, Naomi
Sachs, Teviah

PMID: 38961042

Qiu Y, Chen A, Yu R, Llevenes P, Seen M, Ko NY, Monti S, Denis GV. Insulin Resistance Increases TNBC Aggressiveness and Brain Metastasis via Adipocyte-derived Exosomes. bioRxiv. 2024 May 02.View Related Profiles.

Denis, Gerald
Ko, Naomi
Monti, Stefano

PMID: 38746141; PMCID: PMC11092600; DOI: 10.1101/2024.05.01.592097;

Mayer EL, Ren Y, Wagle N, Mahtani R, Ma C, DeMichele A, Cristofanilli M, Meisel J, Miller KD, Abdou Y, Riley EC, Qamar R, Sharma P, Reid S, Sinclair N, Faggen M, Block CC, Ko N, Partridge AH, Chen WY, DeMeo M, Attaya V, Okpoebo A, Alberti J, Liu Y, Gauthier E, Burstein HJ, Regan MM, Tolaney SM. PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer. J Clin Oncol. 2024 Jun 10; 42(17):2050-2060. PMID: 38513188

Beaulieu-Jones BR, Ha EJ, Fefferman A, Wang J, Chung SH, Tseng JF, Merrill A, Sachs TE, Ko NY, Cassidy MR. Association of Race, Ethnicity, Language, and Insurance with Time to Treatment Initiation Among Women with Breast Cancer at an Urban, Academic, Safety-Net Hospital. Ann Surg Oncol. 2024 Mar; 31(3):1608-1614.View Related Profiles.

Merrill, Andrea
Fefferman, Ann
Beaulieu-Jones, Brendin
Ha, Emily
Tseng, Jennifer
Cassidy, Michael
Ko, Naomi
Sachs, Teviah

PMID: 38017122

Huang HC, Guadamuz JS, Hoskins KF, Ko NY, Calip GS. Risk of contralateral breast cancer among Asian/Pacific Islander women in the United States. Breast Cancer Res Treat. 2024 Feb; 203(3):533-542. PMID: 37897647

Showing 10 of 80 results. Show More

Ko NY, Fikre TG, Buck AK, Restrepo E, Warner ET. Breast cancer survivorship experiences among Black women. Cancer. 2023 Sep; 129(S19):3087-3101. PMID: 37691522

Chung SH, de Geus SWL, Shewmaker G, Romatoski KS, Drake FT, Ko NY, Merrill AL, Hirsch AE, Tseng JF, Sachs TE, Cassidy MR. ASO Visual Abstract: Axillary Lymph Node Dissection is Associated with Improved Survival for Men with Invasive Breast Cancer and Sentinel Node Metastasis. Ann Surg Oncol. 2023 Sep; 30(9):5621-5622.View Related Profiles.

Merrill, Andrea
Hirsch, Ariel
Drake, Frederick
Tseng, Jennifer
Cassidy, Michael
Ko, Naomi
Sachs, Teviah

PMID: 37202569

Fefferman A, Beaulieu-Jones BR, Shewmaker G, Zhang T, Sachs T, Merrill A, Ko NY, Cassidy MR. Association of Race, Ethnicity, Insurance, and Language and Rate of Breast-Conserving Therapy Among Women With Nonmetastatic Breast Cancer at an Urban, Safety-Net Hospital. J Surg Res. 2023 Nov; 291:403-413.View Related Profiles.

Merrill, Andrea
Fefferman, Ann
Beaulieu-Jones, Brendin
Cassidy, Michael
Ko, Naomi
Sachs, Teviah

PMID: 37517348

Chung SH, de Geus SWL, Shewmaker G, Romatoski KS, Drake FT, Ko NY, Merrill AL, Hirsch AE, Tseng JF, Sachs TE, Cassidy MR. Axillary Lymph Node Dissection is Associated with Improved Survival Among Men with Invasive Breast Cancer and Sentinel Node Metastasis. Ann Surg Oncol. 2023 Sep; 30(9):5610-5618.View Related Profiles.

Merrill, Andrea
Hirsch, Ariel
Drake, Frederick
Tseng, Jennifer
Cassidy, Michael
Ko, Naomi
Sachs, Teviah

PMID: 37204557

Odai-Afotey A, Lederman RI, Ko NY, Gagnon H, Fikre T, Gundersen DA, Revette AC, Hershman DL, Crew KD, Keating NL, Freedman RA. Breast cancer treatment receipt and the role of financial stress, health literacy, and numeracy among diverse breast cancer survivors. Breast Cancer Res Treat. 2023 Jul; 200(1):127-137. PMID: 37178432; PMCID: PMC10182756; DOI: 10.1007/s10549-023-06960-w;

Beaulieu-Jones BR, Shewmaker G, Fefferman A, Kenzik K, Zhang T, Drake FT, Sachs TE, Hirsch AE, Merrill A, Ko NY, Cassidy MR. Mitigating disparities in breast cancer treatment at an academic safety-net hospital. Breast Cancer Res Treat. 2023 Apr; 198(3):597-606.View Related Profiles.

Merrill, Andrea
Fefferman, Ann
Hirsch, Ariel
Beaulieu-Jones, Brendin
Drake, Frederick
Kenzik, Kelly
Cassidy, Michael
Ko, Naomi
Sachs, Teviah

PMID: 36826701

Beaulieu-Jones BR, Fefferman A, Woods AP, Shewmaker G, Zhang T, Roh DS, Sachs TE, Merrill A, Ko NY, Cassidy MR. Impact of Race, Ethnicity, Primary Language, and Insurance on Reconstruction after Mastectomy for Patients with Breast Cancer at an Urban, Academic Safety-Net Hospital. J Am Coll Surg. 2023 Jun 01; 236(6):1071-1082.View Related Profiles.

Merrill, Andrea
Fefferman, Ann
Beaulieu-Jones, Brendin
Roh, Daniel
Cassidy, Michael
Ko, Naomi
Sachs, Teviah

PMID: 36524735; DOI: 10.1097/XCS.0000000000000531;

Patel JV, Hughes DM, Ko NY. OPTIMAL Breast Cancer Care: Effect of an Outpatient Pharmacy Team to Improve Management and Adherence to Oral Cancer Treatment. JCO Oncol Pract. 2023 Mar; 19(3):e306-e314.View Related Profiles.

Hughes, David
Patel, Jasmine
Ko, Naomi

PMID: 36480784; DOI: 10.1200/OP.22.00135;

Freedman RA, Ko NY, Lederman RI, Gagnon H, Fikre T, Gundersen DA, Revette AC, Odai-Afotey A, Kantor O, Hershman DL, Crew KD, Keating NL. Breast cancer knowledge and understanding treatment rationales among diverse breast cancer survivors. Breast Cancer Res Treat. 2022 Dec; 196(3):623-633. PMID: 36220997; PMCID: PMC9552717; DOI: 10.1007/s10549-022-06752-8;

Choi JJ, Fikre T, Fischman A, Buck AK, Ko NY. The Role of Race and Insurance Status in Access to Genetic Counseling and Testing Among High-Risk Breast Cancer Patients. Oncologist. 2022 Oct 01; 27(10):832-838. PMID: 36124631; PMCID: PMC9526492; DOI: 10.1093/oncolo/oyac132;

Smith CEP, Marcom PK, Mitri Z, Ko NY. Predictors of long-term durable response in de novo HER2-positive metastatic breast cancer and the real-world treatment experience at two institutions. Breast Cancer Res Treat. 2022 Nov; 196(1):215-220.View Related Profiles.

Smith, Claire
Ko, Naomi

PMID: 36087190; DOI: 10.1007/s10549-022-06718-w;

Restrepo E, Ko N, Warner ET. An evaluation of readability and understandability of online education materials for breast cancer survivors. J Cancer Surviv. 2024 Apr; 18(2):457-465. PMID: 35913680

Irwin KE, Ko N, Walsh EP, Decker V, Arrillaga-Romany I, Plotkin SR, Franas J, Gorton E, Moy B. Developing a Virtual Equity Hub: Adapting the Tumor Board Model for Equity in Cancer Care. Oncologist. 2022 Jul 05; 27(7):518-524. PMID: 35443045; PMCID: PMC9256021; DOI: 10.1093/oncolo/oyac069;

Battaglia TA, Gunn CM, Bak SM, Flacks J, Nelson KP, Wang N, Ko NY, Morton SJ. Patient navigation to address sociolegal barriers for patients with cancer: A comparative-effectiveness study. Cancer. 2022 Jul 01; 128 Suppl 13:2623-2635.View Related Profiles.

Gunn, Christine
Nelson, Kerrie
Ko, Naomi
Battaglia, Tracy

PMID: 35699610; PMCID: PMC10152516; DOI: 10.1002/cncr.33965;

Huang HC, Smart MH, Zolekar A, Deng H, Hubbard CC, Hoskins KF, Ko NY, Guadamuz JS, Calip GS. Impact of socioeconomic status and rurality on cancer-specific survival among women with de novo metastatic breast cancer by race/ethnicity. Breast Cancer Res Treat. 2022 Jun; 193(3):707-716. PMID: 35460499; PMCID: PMC10224670; DOI: 10.1007/s10549-022-06603-6;

Coleman C, Yan CH, Ko NY, Nabulsi NA, Hoskins KF, Chiu BC, Calip GS. Physical functioning, frailty and risks of locally-advanced breast cancer among older women. Breast. 2022 Aug; 64:19-28. PMID: 35468476; PMCID: PMC9039876; DOI: 10.1016/j.breast.2022.04.005;

Calip GS, Nabulsi NA, Hubbard C, Asfaw AA, Lee I, Zhou J, Cueto J, Mitra D, Ko NY, Hoskins KF, Law EH. Impact of time to distant recurrence on breast cancer-specific mortality in hormone receptor-positive breast cancer. Cancer Causes Control. 2022 May; 33(5):793-799. PMID: 35226243; PMCID: PMC9010392; DOI: 10.1007/s10552-022-01561-2;

Mukand NH, Ko NY, Nabulsi NA, Hubbard CC, Chiu BC, Hoskins KF, Calip GS. The association between physical health-related quality of life, physical functioning, and risk of contralateral breast cancer among older women. Breast Cancer. 2022 Mar; 29(2):287-295. PMID: 34797467; PMCID: PMC8885772; DOI: 10.1007/s12282-021-01309-x;

LeClair AM, Battaglia TA, Casanova NL, Haas JS, Freund KM, Moy B, Parsons SK, Ko NY, Ross J, Ohrenberger E, Mullikin KR, Lemon SC. Assessment of patient navigation programs for breast cancer patients across the city of Boston. Support Care Cancer. 2022 Mar; 30(3):2435-2443.View Related Profiles.

Ko, Naomi
Battaglia, Tracy

PMID: 34767089; PMCID: PMC8962605; DOI: 10.1007/s00520-021-06675-y;

Zhou J, Cueto J, Ko NY, Hoskins KF, Nabulsi NA, Asfaw AA, Hubbard CC, Mitra D, Calip GS, Law EH. Population-based recurrence rates among older women with HR-positive, HER2-negative early breast cancer: Clinical risk factors, frailty status, and differences by race. Breast. 2021 Oct; 59:367-375. PMID: 34419726; PMCID: PMC8379689; DOI: 10.1016/j.breast.2021.08.005;

Yan CH, Coleman C, Nabulsi NA, Chiu BC, Ko NY, Hoskins K, Calip GS. Associations between frailty and cancer-specific mortality among older women with breast cancer. Breast Cancer Res Treat. 2021 Oct; 189(3):769-779. PMID: 34241741

Zhou J, Sweiss K, Han J, Ko NY, Patel PR, Chiu BC, Calip GS. Evaluation of Frequency of Administration of Intravenous Bisphosphonate and Recurrent Skeletal-Related Events in Patients With Multiple Myeloma. JAMA Netw Open. 2021 07 01; 4(7):e2118410. PMID: 34313746; PMCID: PMC8316999; DOI: 10.1001/jamanetworkopen.2021.18410;

Spink S, Teng F, Pera V, Peterson H, Cormier T, Sauer-Budge A, Chargin D, Brookfield S, Eggebrecht A, Ko NY, Roblyer D. High optode-density wearable diffuse optical probe for monitoring paced breathing hemodynamics in breast tissue. J Biomed Opt. 2021 06; 26(6).View Related Profiles.

Roblyer, Darren
Ko, Naomi

PMID: 34080400; PMCID: PMC8170390; DOI: 10.1117/1.JBO.26.6.062708;

Hoskins KF, Danciu OC, Ko NY, Calip GS. Association of Race/Ethnicity and the 21-Gene Recurrence Score With Breast Cancer-Specific Mortality Among US Women. JAMA Oncol. 2021 03 01; 7(3):370-378. PMID: 33475714; PMCID: PMC7821091; DOI: 10.1001/jamaoncol.2020.7320;

Chen K, Abbassi M, Ko NY. A Shock-Like Pain and Inability to Ambulate: Thoracic Spinal Cord Compression from Hepatocellular Carcinoma. Case Rep Oncol. 2021 Jan-Apr; 14(1):56-61. PMID: 33776682; PMCID: PMC7983535; DOI: 10.1159/000509511;

Zhou J, Sweiss K, Nutescu EA, Han J, Patel PR, Ko NY, Lee TA, Chiu BC, Calip GS. Racial Disparities in Intravenous Bisphosphonate Use Among Older Patients With Multiple Myeloma Enrolled in Medicare. JCO Oncol Pract. 2021 03; 17(3):e294-e312. PMID: 33449809; PMCID: PMC8257921; DOI: 10.1200/OP.20.00479;

Poulson MR, Beaulieu-Jones BR, Kenzik KM, Dechert TA, Ko NY, Sachs TE, Cassidy MR. Residential Racial Segregation and Disparities in Breast Cancer Presentation, Treatment, and Survival. Ann Surg. 2021 01 01; 273(1):3-9.View Related Profiles.

Beaulieu-Jones, Brendin
Kenzik, Kelly
Cassidy, Michael
Poulson, Michael
Ko, Naomi
Sachs, Teviah
Dechert, Tracey

PMID: 32889878

Gupta VK, Dennis M, Mann E, Jacobson JO, Ko NY. Identifying Actionable Causes of Potentially Avoidable Readmissions to an Oncology Service at a Safety Net Hospital. JCO Oncol Pract. 2021 03; 17(3):e454-e460.View Related Profiles.

Mann, Emily
Ko, Naomi

PMID: 33290161

Oladeru OT, Hirsch AE, Ko NY. Trends in Deescalation of Localized Breast Cancer Treatment and Caution for the Most Vulnerable Patients-A Look Back on the Decade That Was. JAMA Oncol. 2020 12 01; 6(12):1863-1864.View Related Profiles.

Hirsch, Ariel
Ko, Naomi

PMID: 32970115

Lombardi FL, Jafari N, Bertrand KA, Oshry LJ, Cassidy MR, Ko NY, Denis GV. Novel semi-automated algorithm for high-throughput quantification of adipocyte size in breast adipose tissue, with applications for breast cancer microenvironment. Adipocyte. 2020 12; 9(1):313-325.View Related Profiles.

Denis, Gerald
Bertrand, Kimberly
Oshry, Lauren
Cassidy, Michael
Ko, Naomi
Jafari, Naser

PMID: 32633194; PMCID: PMC7469507; DOI: 10.1080/21623945.2020.1787582;

Ko NY, Qureshi MM, Oladeru OT, Cassidy MR, Oshry L, Truong MT, Hirsch AE. Racial differences in genomic testing and receipt of endocrine therapy in early-stage breast cancer. Breast Cancer Res Treat. 2020 Dec; 184(3):849-859.View Related Profiles.

Hirsch, Ariel
Oshry, Lauren
Cassidy, Michael
Truong, Minh
Qureshi, Muhammad
Ko, Naomi

PMID: 32888137

Mukand NH, Zolekar A, Ko NY, Calip GS. Risks of Second Primary Gynecologic Cancers following Ovarian Cancer Treatment in Asian Ethnic Subgroups in the United States, 2000-2016. Cancer Epidemiol Biomarkers Prev. 2020 11; 29(11):2220-2229. PMID: 32856609; PMCID: PMC10772992; DOI: 10.1158/1055-9965.EPI-20-0095;

Ghosh S, Chen ML, Weinberg J, Fikre T, Ko NY. Hepatitis C Virus Infection and Chemotherapy in Breast Cancer: A Retrospective Chart Analysis. Oncologist. 2020 10; 25(10):845-852.View Related Profiles.

Weinberg, Janice
Ko, Naomi

PMID: 32488966; PMCID: PMC7543236; DOI: 10.1634/theoncologist.2020-0172;

Festa K, Hirsch AE, Cassidy MR, Oshry L, Quinn K, Sullivan MM, Ko NY. Breast Cancer Treatment Delays at an Urban Safety Net Hospital Among Women Experiencing Homelessness. J Community Health. 2020 06; 45(3):452-457.View Related Profiles.

Hirsch, Ariel
Quinn, Kathryn
Oshry, Lauren
Cassidy, Michael
Ko, Naomi

PMID: 31625050

Coleman C, Yan C, Ko NY, Chiu B, Calip GS. PCN181 PHYSICAL FUNCTIONING, FRAILTY AND RISKS OF LOCALLY-ADVANCED BREAST CANCER AMONG OLDER WOMEN. Value in Health. 2020; 23:S55. View Publication
McCormick C, Ko NY, Calip GS. MC3 DISPARITIES IN HEALTH INSURANCE STATUS AMONG YOUNG ADULT CANCER PATIENTS IN STATES WITH AND WITHOUT MEDICAID EXPANSION: ANALYSES OF THE SURVEILLANCE, EPIDEMIOLOGY AND END RESULTS REGISTRIES, 2007 - 2016. Value in Health. 2020; 23. View Publication

Nabulsi NA, Alobaidi A, Talon B, Asfaw AA, Zhou J, Sharp LK, Sweiss K, Patel PR, Ko NY, Chiu BC, Calip GS. Self-reported health and survival in older patients diagnosed with multiple myeloma. Cancer Causes Control. 2020 Jul; 31(7):641-650. PMID: 32356139; PMCID: PMC7274896; DOI: 10.1007/s10552-020-01305-0;

Zhou J, Asfaw AA, Nabulsi NA, Mukand NA, Lee I, Ko NY, Boudreau DM, Calip GS. HSR20-113: Diabetes Complications and Risks of Breast Cancer Recurrence Among Older Women. Journal of the National Comprehensive Cancer Network. 2020; 18(3.5). View Publication

Tank A, Peterson HM, Pera V, Tabassum S, Leproux A, O'Sullivan T, Jones E, Cabral H, Ko N, Mehta RS, Tromberg BJ, Roblyer D. Diffuse optical spectroscopic imaging reveals distinct early breast tumor hemodynamic responses to metronomic and maximum tolerated dose regimens. Breast Cancer Res. 2020 03 13; 22(1):29.View Related Profiles.

Roblyer, Darren
Cabral, Howard
Ko, Naomi

PMID: 32169100; PMCID: PMC7071774; DOI: 10.1186/s13058-020-01262-1;

Ko NY, Hong S, Winn RA, Calip GS. Association of Insurance Status and Racial Disparities With the Detection of Early-Stage Breast Cancer. JAMA Oncol. 2020 03 01; 6(3):385-392. PMID: 31917398; PMCID: PMC6990828; DOI: 10.1001/jamaoncol.2019.5672;

Kim KN, Qureshi MM, Huang D, Ko NY, Cassidy M, Oshry L, Hirsch AE. The Impact of Locoregional Treatment on Survival in Patients With Metastatic Breast Cancer: A National Cancer Database Analysis. Clin Breast Cancer. 2020 04; 20(2):e200-e213.View Related Profiles.

Hirsch, Ariel
Oshry, Lauren
Cassidy, Michael
Qureshi, Muhammad
Ko, Naomi

PMID: 32089454

Alobaidi A, Nabulsi NA, Talon B, Asfaw AA, Zhou J, Sharp LK, Sweiss K, Patel PR, Ko NY, Chiu BC, Calip GS. Depressive symptoms, mental health-related quality of life, and survival among older patients with multiple myeloma. Support Care Cancer. 2020 Sep; 28(9):4097-4106. PMID: 31872292; PMCID: PMC7308221; DOI: 10.1007/s00520-019-05246-6;

Kim NE, Conway-Pearson L, Kavanah M, Mendez J, Sachs TF, Drake FT, Ko NY, McAneny D, Cassidy MR. Standardized Risk Assessment and Risk-Stratified Venous Thromboembolism Prophylaxis for Patients Undergoing Breast Operation. J Am Coll Surg. 2020 06; 230(6):947-955.View Related Profiles.

McAneny, David
Drake, Frederick
Kavanah, Maureen
Cassidy, Michael
Ko, Naomi

PMID: 31809861

Guadamuz JS, Ozenberger K, Qato DM, Ko NY, Saffore CD, Adimadhyam S, Cha AS, Moran KM, Sweiss K, Patel PR, Chiu BC, Calip GS. Mediation analyses of socioeconomic factors determining racial differences in the treatment of diffuse large B-cell lymphoma in a cohort of older adults. Medicine (Baltimore). 2019 Nov; 98(46):e17960. PMID: 31725657; PMCID: PMC6867777; DOI: 10.1097/MD.0000000000017960;

Freund KM, Haas JS, Lemon SC, Burns White K, Casanova N, Dominici LS, Erban JK, Freedman RA, James TA, Ko NY, LeClair AM, Moy B, Parsons SK, Battaglia TA. Standardized activities for lay patient navigators in breast cancer care: Recommendations from a citywide implementation study. Cancer. 2019 12 15; 125(24):4532-4540.View Related Profiles.

Ko, Naomi
Battaglia, Tracy

PMID: 31449680; PMCID: PMC6891116; DOI: 10.1002/cncr.32432;

Ko NY, Bak S, Gunn C, Nelson KP, Bowen D, Flacks J, Morton S, Parker V, Mendez J, Battaglia TA. An Innovation in Patient Navigation: Background, Methods, and Measures. Journal of Oncology Navigation and Survivorship. 2019; 10(6). View Publication

Nwabudike SM, Edwards CV, Akinboro O, Quinn K, Sarosiek S, Ko N. Cyclin-Dependent Kinase 4/6 Inhibitor (Palbociclib) Induced Aplastic Anemia in a Patient with Metastatic Breast Cancer. Case Rep Hematol. 2018; 2018:9249506.View Related Profiles.

Edwards, Camille
Quinn, Kathryn
Ko, Naomi
Sarosiek, Shayna

PMID: 30647983; PMCID: PMC6311830; DOI: 10.1155/2018/9249506;

Calip GS, Moran KM, Sweiss KI, Patel PR, Wu Z, Adimadhyam S, Lee TA, Ko NY, Quigley JG, Chiu BC. Myelodysplastic syndrome and acute myeloid leukemia after receipt of granulocyte colony-stimulating factors in older patients with non-Hodgkin lymphoma. Cancer. 2019 04 01; 125(7):1143-1154. PMID: 30548485; PMCID: PMC6420387; DOI: 10.1002/cncr.31914;

Saffore CD, Ko NY, Holmes HM, Patel PR, Sweiss K, Adimadhyam S, Chiu BC, Calip GS. Treatment of older patients with diffuse large B-cell lymphoma and mild cognitive impairment or dementia. J Geriatr Oncol. 2019 05; 10(3):510-513. PMID: 30270197

Khanna S, Kim KN, Qureshi MM, Agarwal A, Parikh D, Ko NY, Rand AE, Hirsch AE. Impact of patient demographics, tumor characteristics, and treatment type on treatment delay throughout breast cancer care at a diverse academic medical center. Int J Womens Health. 2017; 9:887-896.View Related Profiles.

Hirsch, Ariel
Qureshi, Muhammad
Ko, Naomi

PMID: 29255374; PMCID: PMC5723124; DOI: 10.2147/IJWH.S150064;

Gunn CM, Parker VA, Bak SM, Ko N, Nelson KP, Battaglia TA. Social Network Structures of Breast Cancer Patients and the Contributing Role of Patient Navigators. Oncologist. 2017 Aug; 22(8):918-924.View Related Profiles.

Gunn, Christine
Nelson, Kerrie
Ko, Naomi
Battaglia, Tracy
Parker, Victoria

PMID: 28559408; PMCID: PMC5553958; DOI: 10.1634/theoncologist.2016-0440;

Calip GS, Xing S, Jun DH, Lee WJ, Hoskins KF, Ko NY. Polypharmacy and Adherence to Adjuvant Endocrine Therapy for Breast Cancer. J Oncol Pract. 2017 May; 13(5):e451-e462. PMID: 28287854; DOI: 10.1200/JOP.2016.018317;

Wanchoo P, Larrison C, Rosenberg C, Ko N, Cantril C, Moeller N, Parikh R, Djordjevic AM. Identifying Educational Needs of the Multidisciplinary Cancer Team in the Treatment of Metastatic Breast Cancer. J Natl Compr Canc Netw. 2017 Feb; 15(2):205-212. PMID: 28188190

Teng F, Cormier T, Sauer-Budge A, Chaudhury R, Pera V, Istfan R, Chargin D, Brookfield S, Ko NY, Roblyer DM. Wearable near-infrared optical probe for continuous monitoring during breast cancer neoadjuvant chemotherapy infusions. J Biomed Opt. 2017 01 01; 22(1):14001.View Related Profiles.

Roblyer, Darren
Ko, Naomi

PMID: 28114449; PMCID: PMC5289133; DOI: 10.1117/1.JBO.22.1.014001;

Tran A, Sarosiek S, Ko NY. Challenges in the use of immunotherapy in metastatic melanoma. BMJ Case Rep. 2016 Nov 18; 2016.View Related Profiles.

Tran, Ashley
Ko, Naomi
Sarosiek, Shayna

PMID: 27864299; PMCID: PMC5129100; DOI: 10.1136/bcr-2016-216681;

Strissel KJ, Nicholas DA, Castagne-Charlotin M, Ko N, Denis GV. Correction to "Barriers to Obtaining Sera and Tissue Specimens of African-American Women for the Advancement of Cancer Research". Clin Med Insights Womens Health. 2016; 9:35.View Related Profiles.

Denis, Gerald
Ko, Naomi

PMID: 27695380; PMCID: PMC5022798; DOI: 10.4137/CMWH.S40655;

Battaglia TA, Darnell JS, Ko N, Snyder F, Paskett ED, Wells KJ, Whitley EM, Griggs JJ, Karnad A, Young H, Warren-Mears V, Simon MA, Calhoun E. The impact of patient navigation on the delivery of diagnostic breast cancer care in the National Patient Navigation Research Program: a prospective meta-analysis. Breast Cancer Res Treat. 2016 Aug; 158(3):523-34.View Related Profiles.

Ko, Naomi
Battaglia, Tracy

PMID: 27432417; PMCID: PMC5216421; DOI: 10.1007/s10549-016-3887-8;

Strissel KJ, Nicholas DA, Castagne-Charlotin M, Ko N, Denis GV. Barriers to Obtaining Sera and Tissue Specimens of African-American Women for the Advancement of Cancer Research. Clin Med Insights Womens Health. 2016; 9(Suppl 1):57-61.View Related Profiles.

Denis, Gerald
Ko, Naomi

PMID: 27441007; PMCID: PMC4946585; DOI: 10.4137/CMWH.S34698;

Pulido V, Lee SY, Ko NY. Arriving at the Right Diagnosis in an Era of Precision Medicine. Case Rep Oncol. 2016 May-Aug; 9(2):351-357.View Related Profiles.

Ko, Naomi
Nguyen, Vina

PMID: 27752243; PMCID: PMC5057066; DOI: 10.1159/000447351;

Ko NY, Battaglia TA, Gupta-Lawrence R, Schiller J, Gunn C, Festa K, Nelson K, Flacks J, Morton SJ, Rosen JE. Burden of socio-legal concerns among vulnerable patients seeking cancer care services at an urban safety-net hospital: a cross-sectional survey. BMC Health Serv Res. 2016 Jun 14; 16:196.View Related Profiles.

Gunn, Christine
Nelson, Kerrie
Ko, Naomi
Battaglia, Tracy

PMID: 27296566; PMCID: PMC4906581; DOI: 10.1186/s12913-016-1443-1;

Ko NY, Snyder FR, Raich PC, Paskett ED, Dudley DJ, Lee JH, Levine PH, Freund KM. Racial and ethnic differences in patient navigation: Results from the Patient Navigation Research Program. Cancer. 2016 Sep 01; 122(17):2715-22. PMID: 27227342; PMCID: PMC4992408; DOI: 10.1002/cncr.30109;

Walker A, Ko N. Bringing Medicine to the Digital Age via Hackathons and Beyond. J Med Syst. 2016 Apr; 40(4):98. PMID: 26872780

Solanki PA, Ko NY, Qato DM, Calip GS. Risk of cancer-specific, cardiovascular, and all-cause mortality among Asian and Pacific Islander breast cancer survivors in the United States, 1991-2011. Springerplus. 2016; 5:82. PMID: 26844029; PMCID: PMC4728166; DOI: 10.1186/s40064-016-1726-3;

Walker A, Ko NY. Bringing Medicine to the Digital Age via Hackathons and Beyond. J Med Syst. 2016; 4(40):98.

Ko NY, Fu JL, Lane SC, Finn K, Allten S, Vassilakis N, Stober L, Kachnic L, Battaglia TA. Cancer clinical trial enrollment of diverse and underserved patients within an urban safety net hospital. J Community Support Oncol. 2015 Dec; 13(12):429-35.View Related Profiles.

Ko, Naomi
Battaglia, Tracy

PMID: 26863873; DOI: 10.12788/jcso.0181;

Calip GS, Law EH, Ko NY. Racial and ethnic differences in risk of second primary cancers among breast cancer survivors. Breast Cancer Res Treat. 2015 Jun; 151(3):687-96. PMID: 26012645; PMCID: PMC4501770; DOI: 10.1007/s10549-015-3439-7;

Ko NY, Darnell JS, Calhoun E, Freund KM, Wells KJ, Shapiro CL, Dudley DJ, Patierno SR, Fiscella K, Raich P, Battaglia TA. Can patient navigation improve receipt of recommended breast cancer care? Evidence from the National Patient Navigation Research Program. J Clin Oncol. 2014 Sep 1; 32(25):2758-64.View Related Profiles.

Ko, Naomi
Battaglia, Tracy

PMID: 25071111; PMCID: PMC4145185; DOI: 10.1200/JCO.2013.53.6037;

Crowley MM, McCoy ME, Bak SM, Caron SE, Ko NY, Kachnic LA, Alvis F, Battaglia TA. Challenges in the delivery of quality breast cancer care: initiation of adjuvant hormone therapy at an urban safety net hospital. J Oncol Pract. 2014 Mar; 10(2):e107-12.View Related Profiles.

Kachnic, Lisa
Ko, Naomi
Battaglia, Tracy

PMID: 24345397; PMCID: PMC3948707; DOI: 10.1200/JOP.2013.001164;

Raj A, Ko N, Battaglia TA, Chabner BA, Moy B. Patient navigation for underserved patients diagnosed with breast cancer. Oncologist. 2012; 17(8):1027-31.View Related Profiles.

Ko, Naomi
Battaglia, Tracy

PMID: 22752069; PMCID: PMC3425520; DOI: 10.1634/theoncologist.2012-0191;

Ko N, Averett L, Brown C, Wiener CM. An unexpected finding. Am J Med. 2005 May; 118(5):477-9. PMID: 15866248; DOI: 10.1016/j.amjmed.2005.02.024;

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 80 publications over 15 distinct years, with a maximum of 14 publications in 2020

Bar chart showing 80 publications over 15 distinct years, with a maximum of 14 publications in 2020

Year	Publications
2005	1
2012	1
2013	1
2014	1
2015	2
2016	10
2017	5
2018	3
2019	5
2020	14
2021	10
2022	11
2023	8
2024	5
2025	3

Media Mentions
Featured Videos

BMC Catwalk 2019

BMC Catwalk 2016

Maria's Story

Using Light to Monitor Blood Pressure and Track Cancer Treatment Progress

The Brink 11/7/2024

Varied efforts aim to close gaps in care for Black women facing breast cancer

The Bay State Banner 10/9/2024

The US will see record-breaking number of new cancer cases in 2024

Futurity 1/31/2024

New Cancer Cases Are Expected to Pass 2 Million This Year. What Does That Mean for All of Us?

BU Today 1/30/2024

Report shows breast cancer survival rates worst among Black women

The Bay State Banner 11/8/2023

Women of color share their stories of breast cancer treatment and survivorship

WGBH 10/27/2023

'I don't know of a time that was worse': What to know about cancer drug shortages

Becker's Hospital Review 6/15/2023

What’s Behind the Critical Shortage of Drugs for Cancer and Other Diseases

BU Today 6/14/2023

So, when do you need that next mammogram?

The Boston Globe 5/9/2023

Why I Became a Doctor

BU Today 4/3/2023

Consistency of care across US may have ‘biggest impact’ on breast cancer outcomes

Healio 2/17/2022

Racial disparities a ‘harsh reality’ in breast cancer care

Healio 12/30/2021

The Other C: Avoiding Or Delaying Care Because Of The Pandemic

WGBH Basic Black 11/5/2021

Identifying Actionable Causes of Potentially Avoidable Readmissions to an Oncology Service at a Safety Net Hospital.

Physician's Weekly 12/10/2020

Freedom Songs in NH, Affordable Dental Care in Waltham, and New Cancer Research Grants in Boston

iHeartRadio New England Weekend Podcast 10/31/2020

MGH, BMC Study Looks At The Role Race Plays In Treating Breast Cancer

WBZ News 10/30/2020

Insurance status a key clue in closing racial, economic breast cancer treatment gaps

Radiology Business 1/22/2020

Insurance Status Helps Explain Racial Disparities in Cancer Diagnosis

NIH Director’s Blog 1/21/2020

Lack of Insurance Tied to Later Stage of Breast Cancer at Diagnosis

Health Day 1/16/2020

Lack of Insurance Linked to Racial Disparities in Breast Cancer Treatment

Modern Healthcare 1/9/2020

Survivors Share Stories at MCHC’s Breast Health Night

Dorchester Reporter 11/7/2019

5 Myths About Mammograms You Need Not Fear

Exhale Lifestyle 9/12/2019

A Double Diagnosis – Cancer While Poor

The Boston Globe 12/29/2018

Boston Sunday Review: Dr. Naomi Ko

98.5 The Sports Hub 10/7/2018

2022 Arnold Gold Humanism in Medicine Award

2021 BUMG: Excellence in Care Award

2015 MIT Grand Hackathon: First Place

2012 MSCO: Merit Award

2012 ASCO: Merit Award

In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Breast Cancer
Cancer Disparities
Health Services Delivery Research
Health Equity

Available to Mentor as: (Review Mentor Role Definitions):